Krebs medal review: PtdIns3P in tumour suppression 78 Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N & Lopez-Otin C (2007) Tissue-speciﬁc autophagy alterations and increased tumorigenesis in mice deﬁcient in Atg4C ⁄ autophagin-3. J Biol Chem 282, 18573–18583. 79 Bache KG, Slagsvold T & Stenmark H (2004) Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23, 2707–2712. 80 Vaccari T & Bilder D (2005) The Drosophila tumor sup- pressor vps25 prevents nonautonomous overprolifera- tion by regulating notch trafﬁcking. Dev Cell 9, 687–698. 81 Vaccari T, Rusten TE, Menut L, Nezis IP, Brech A, Stenmark H & Bilder D (2009) Comparative analysis of ESCRT-I, ESCRT-II and ESCRT-III function in Drosophila by efﬁcient isolation of ESCRT mutants. J Cell Sci 122, 2413–2423. 82 Thompson BJ, Mathieu J, Sung HH, Loeser E, Rorth P & Cohen SM (2005) Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Dev Cell 9, 711–720. 83 Moberg KH, Schelble S, Burdick SK & Hariharan IK (2005) Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non- cell-autonomous overgrowth. Dev Cell 9, 699–710. 84 Sagona AP & Stenmark H (2010) Cytokinesis and cancer. FEBS Lett 584, 2652–2661. 85 Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274. 86 Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318, 1108–1113. 87 Tsukazaki T, Chiang TA, Davison AF, Attisano L & Wrana JL (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFb receptor. Cell 95, 779–791. 88 Heldin CH, Landstrom M & Moustakas A (2009) Mechanism of TGF-beta signaling to growth arrest, H. Stenmark apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21, 166–176. 89 Bonifacino JS & Hurley JH (2008) Retromer. Curr Opin Cell Biol 20, 427–436. 90 Lorenowicz MJ & Korswagen HC (2009) Sailing with the Wnt: charting the Wnt processing and secretion route. Exp Cell Res 315, 2683–2689. 91 Christoforidis S, Miaczynska M, Ashman K, Wilm M, Zhao L, Yip S-C, Waterﬁeld MD, Backer JM & Zerial M (1999) Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nature Cell Biol 1, 249–252. 92 Murray JT, Panaretou C, Stenmark H, Miaczynska M & Backer JM (2002) Role of Rab5 in the recruitment of hVps34 ⁄ p150 to the early endosome. Trafﬁc 3, 416–427. 93 Stein MP, Feng Y, Cooper KL, Welford AM & Wandinger-Ness A (2003) Human VPS34 and p150 are Rab7 interacting partners. Trafﬁc 4, 754–771. 94 Stenmark H & Gillooly DJ (2001) Intracellular trafﬁck- ing and turnover of phosphatidylinositol 3-phosphate. Semin Cell Dev Biol 12, 193–199. 95 Odorizzi G, Babst M & Emr SD (1998) Fab1p PtdIns(3)P 5-kinase function essential for protein sort- ing in the multivesicular body. Cell 95, 847–858. 96 Cao C, Laporte J, Backer JM, Wandinger-Ness A & Stein MP (2007) Myotubularin lipid phosphatase binds the hVPS15 ⁄ hVPS34 lipid kinase complex on endo- somes. Trafﬁc 8, 1052–1067. 97 Cao C, Backer JM, Laporte J, Bedrick EJ & Wanding- er-Ness A (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafﬁcking. Mol Biol Cell 19, 3334–3346. 98 Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC & Kroemer G (2009) Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 1793, 1524–1532. 99 Brech A, Ahlquist T, Lothe RA & Stenmark H (2009) Autophagy in tumour suppression and promotion. Mol Oncol 3, 366–375. 4848 FEBS Journal 277 (2010) 4837–4848 ª 2010 The Author Journal compilation ª 2010 FEBS